USPTO serial 79426071
AIXPLORE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 31, 2026
- Examiner
- HUDSON, TAMARA BREE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AIXPLORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable or recorded computer software for conducting research in the fields of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; downloadable or recorded computer software for use in antibody discovery and identification; downloadable or recorded artificial intelligence software for facilitating drug discovery, affinity maturation, engineering of biological products, studies of molecular interactions, humanization and identification, drug research, antibody research and design, pharmaceutical research; downloadable or recorded machine learning software for use in drug discovery and identification, drug research, antibody research and design, pharmaceutical research; downloadable software for conducting research and diagnostics in the field of genomics, proteomics, omics and developing biological products; downloadable or recorded big data generation software | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software for use in conducting research in the fields of drug discovery, diagnostics, genetics, proteomics and identification, drug research, antibody, protein, peptide, biological product and chemical product research and design, pharmaceutical research; medical research services in the field of medicine discovery; biological research; scientific analysis and research in the field of drug discovery, affinity maturation, biological product engineering, studies of molecular interactions, humanization and identification, drug research, antibody, protein, peptide, biological and chemical research and design, pharmaceutical research; antibody sequencing technology research; research and development services related to AI in the field of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; research and development in the field of drug discovery and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals; research and development services in the field of antibody technology; electronic data storage and providing on-line non-downloadable software using artificial intelligence (AI) for machine learning | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 30, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 31, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 31, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 10, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 10, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 15, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 24, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 24, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 24, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 5, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 17, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 17, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 9, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 8, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 3, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 22, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 22, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 19, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |